Patent details
EP2753187
Title:
METHOD FOR PREVENTING AND/OR TREATING INSULIN RESISTANCE
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
Ok
Cancel
You have not selected any documents
Ok
Basic Information
Publication number:
EP2753187
WO Application Number:
NL2012050592
Type:
European Patent Granted for NL
Status:
Patent in Force
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP12758652.7
WO Publication Number:
WO2013032328
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
Netherlands (NL)
Publications:
Dates
Filing date:
30/08/2012
Grant date:
24/10/2018
EP Publication Date:
16/07/2014
WO Publication Date:
07/03/2013
Claims Translations Received Date:
Claims Translation B1 Received Date:
18/01/2019
Claims Translation B2 Received Date:
03/10/2025
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
24/10/2018
EP B1 Publication Date:
24/10/2018
EP B2 Publication Date:
06/08/2025
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
29/08/2032
Lapsed By Expiration Date:
Patent Validated Date:
23/10/2025
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:
Applicant/holder
From:
09/12/2025
Name:
Caelus Lifesciences IP B.V.
Address:
40 B, Westerdoksdijk, 1013 AE, AMSTERDAM, Netherlands (NL)
From:
09/12/2025
Name:
Stichting Amsterdam UMC
Address:
De Boelelaan 1117, 1081 HV, Amsterdam, Netherlands (NL)
Historical Applicant/holder
From:
23/02/2024
To:
09/12/2025
Name:
Caelus Pharmaceuticals B.V.
Address:
50, Rondweg, 3474 KG, ZEGVELD, Netherlands (NL)
From:
23/02/2024
To:
09/12/2025
Name:
Stichting Amsterdam UMC
Address:
De Boelelaan 1117, 1081 HV, Amsterdam, Netherlands (NL)
From:
24/10/2018
To:
23/02/2024
Name:
Caelus Pharmaceuticals B.V.
Address:
50, Rondweg, 3474 KG Zegveld, Netherlands (NL)
From:
24/10/2018
To:
23/02/2024
Name:
Academisch Medisch Centrum
Address:
Meibergdreef 9, 1105 AZ, AMSTERDAM, Netherlands (NL)
Agent
Name:
ir. J.C. Volmer c.s.
From:
21/02/2019
Address:
Exter Polak & Charlouis B.V.
Postbus 3241, 2280 GE, Rijswijk, Netherlands (NL)
To:
Inventor
1
Name:
NIEUWDORP, Max
Address:
NL-1091 EN Amsterdam, Netherlands (NL)
2
Name:
DE VOS, Willem Meindert
Address:
NL-6717 LM Ede, Netherlands (NL)
Priority
1
Priority Patent Number:
2007319
Priority Date:
30/08/2011
Priority Country:
Netherlands (NL)
2
Priority Patent Number:
201161528931 P
Priority Date:
30/08/2011
Priority Country:
United States of America (US)
Classification
IPC or IDT classification:
A23L 33/135 ;
A23L 2/52 ;
A61K 35/74 ;
A61P 3/04 ;
A61P 3/06 ;
A23K 10/16 ;
Publication
Bulletin
1
Bulletin Heading:
CO
Journal edition number:
51/25
Publication date:
17/12/2025
Description:
Changes in the Netherlands Patent Register
2
Bulletin Heading:
EP5
Journal edition number:
44/25
Publication date:
29/10/2025
Description:
European patents granted in amended form for the Netherlands in which an amended translation was filed ex Article 52 par. 6 of the NL Patent Law 1995
3
Bulletin Heading:
EP4
Journal edition number:
32/25
Publication date:
06/08/2025
Description:
European patents granted in amended form for the Netherlands
4
Bulletin Heading:
MED
Journal edition number:
32/25
Publication date:
06/08/2025
Description:
Other communications
5
Bulletin Heading:
CO
Journal edition number:
11/24
Publication date:
13/03/2024
Description:
Changes in the Netherlands Patent Register
6
Bulletin Heading:
EP3
Journal edition number:
09/19
Publication date:
27/02/2019
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995
7
Bulletin Heading:
EP2
Journal edition number:
44/18
Publication date:
24/10/2018
Description:
European patents granted for the Netherlands
European Patent Bulletin
1
Issue number:
202532
Publication date:
06/08/2025
Description:
Patent maintained (B2 publication)
2
Issue number:
201843
Publication date:
24/10/2018
Description:
Grant (B1)
Deed
Change of owner(s)
Change Kind/ Decision Type:
Assignment
Deed Number:
RC202501996B
Date Registered:
09/12/2025
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. J.C. Volmer c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:
Added Owner(s)
1
Name:
Stichting Amsterdam UMC
Address:
De Boelelaan 1117, 1081 HV, Amsterdam, Netherlands (NL)
2
Name:
Caelus Lifesciences IP B.V.
Address:
40 B, Westerdoksdijk, 1013 AE, AMSTERDAM, Netherlands (NL)
Changed Pledgee
Name:
Address:
Removed Usufructuary
Name:
Address:
Added Usufructuary
Name:
Address:
Changed Usufructuary
Name:
Address:
Change of owner(s)
Change Kind/ Decision Type:
Assignment
Deed Number:
RC202400407F
Date Registered:
23/02/2024
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
Amsterdam UMC
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:
Added Owner(s)
1
Name:
Caelus Pharmaceuticals B.V.
Address:
50, Rondweg, 3474 KG, ZEGVELD, Netherlands (NL)
2
Name:
Stichting Amsterdam UMC
Address:
De Boelelaan 1117, 1081 HV, Amsterdam, Netherlands (NL)
Changed Pledgee
Name:
Address:
Removed Usufructuary
Name:
Address:
Added Usufructuary
Name:
Address:
Changed Usufructuary
Name:
Address:
Annual Fee
Annual Fee(s) Due Date:
31/08/2026
Annual Fee Number:
15
Annual Fee Amount:
900 Euro
Last Annual Payment Date:
25/08/2025
Last Annual Fee Paid Number:
14
Last Annual Fee Paid Amount:
800 Euro
Payer:
Exter Polak & Charlouis BV
Filing date
Document type
Document Description
Number of pages
File Type
22/10/2025
Outgoing Correspondence
Letter no formal defects
1
PDF
/8/6/3/0/3/0800330368/docs/ep12758652.7_3_ep2753187678986l271.pdf
03/10/2025
Claims
First filed claims
2
PDF
/8/6/3/0/3/0800330368/docs/ep12758652.7_2_claims20251003161507348.pdf
21/02/2019
Outgoing Correspondence
Letter no formal defects
1
PDF
/8/6/3/0/3/0800330368/docs/ep12758652.7_1_255210l271.pdf
18/01/2019
Claims
First filed claims
2
PDF
/8/6/3/0/3/0800330368/docs/ep12758652.7_0_claims20190118124757631.pdf